Post-earnings recap
Reported
Thu, May 8, 2025
EPS actual
$1.24
EPS est.
$1.22
EPS surprise
+1.81%
1-day move
+5.85%
Est. EPS
—
Est. Rev
—
Impl. Move
—
The positive EPS surprise indicates that Haemonetics Corp is managing its costs effectively, which has likely contributed to the stock's 5.85% increase. Investors may view this performance as a sign of resilience in a challenging market. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.24 | N/A | +1.81% |
Management expressed satisfaction with the EPS results, highlighting a commitment to operational improvements. They emphasized the importance of innovation in their future strategy.
We are pleased with our EPS performance this quarter.
Our focus remains on driving operational efficiency and innovation.